World

 

Español

 

Guyana


Trinidad
& Tobago

 






Very usefull links



PW
Bookstore





News links

AP

AFP

Aljazeera

Dow Jones

Oil price

Reuters

Bloomberg

Views and News
from
Norway

 

 

 

 

Brazil's president Bolsonaro approval
at highest level since 2018

Bloomberg

Jair Bolsonaro

By Fernando Travaglini/Bloomberg

SAO PAULO
Petroleumworld 12 15 2020

President Jair Bolsonaro’s approval rating remained stable at the highest level since he was elected in 2018 even as the government phases out popular monthly stipends, according to a Datafolha poll released by Folha de S. Paulo. Roughly 37% of citizens rate the president as good or great, which is unchanged from August and up from 32% in June.

Respondents who rate Bolsonaro as bad or terrible fell to 32% from 34% previously, while 29% see Bolsonaro as average. The poll also shows that 37% of Brazilians never trust the president; 21% always do and 39% sometimes do. Datafolha surveyed 2,016 people by phone on Dec. 8 and 10; margin of error is plus or minus 2 percentage points.

Congressional Vote

Bolsonaro’s administration is still trying to vote on some parts of a bill that supports the public spending cap. The government whip may include components in another piece of legislation, which is scheduled for a vote this week, lower house speaker Rodrigo Maia said in a interview with Valor Economico. Maia says the proposal can be presented as an amendment, but that strategy can be seen as unconstitutional.

On Friday, the rapporteur of the proposal that protects the spending cap, Senator Marcio Bittar, said his report would be put off until next year.

Vaccination

The Supreme Court gave Health Minister Eduardo Pazuello 48 hours to set a date for vaccinations against Covid-19 in Brazil, according to local newspapers. On Friday, the Brazil’s Health Ministry delivered a national immunization plan to the court following a request by Justice Ricardo Lewandowski. In the document, the Ministry says that 300 million doses are guaranteed, including more than 180 million coming from the agreement with Oxford-AstraZeneca, 42 million provided by Covax Facility and another 70 million would come from Pfizer, according to O Estado de S. Paulo. The Coronavac vaccine, developed by Sinovac Biotech Ltd. in partnership with the Butantan Institute, was not mentioned in the plan.

Half of Brazilians wouldn’t be willing to take the Covid-19 vaccine that’s being developed by China’s Sinovac Biotech Ltd. with Butantan in Sao Paulo, a Datafolha poll shows. The survey also showed the number of Brazilians who don’t plan to take any Covid-19 vaccine increased to 22% from 9% in August. Brazil has a total of 6,901,952 virus cases and 181,402 related deaths.

Succession

Under pressure from allies, lower house speaker Maia may announce on Monday who he will support to succeed him, says O Globo. So far, only Arthur Lira has announced his candidacy for the job. The conflicts between lower house and the Bolsonaro’s administration may continue even if Lira is elected, says Valor Economico. In the Senate, the MDB party is trying to unite to run for presidency, says the newspaper.

______________

TOP

Contact: editor@petroleumworld.com,

Editor & Publisher:Elio Ohep /
Contact Email: editor@petroleumworld.com

CopyRight © 1999-2020, Elio Ohep A. - All Rights Reserved. Legal Information

PW in Top 100 Energy Sites

CopyRight©1999-2020, Petroleumworld   / Elio Ohep - All rights reserved

 

This site is a public free site and it contains copyrighted material the use of which has not always been specifically authorized by the copyright owner.We are making such material available in our efforts to advance understanding of business, environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have chosen to view the included information for research, information, and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission fromPetroleumworld or the copyright owner of the material.